Traditional drug design involved origins from natural sources through accidental discoveries, not based on specific targets. Methods included random screening, trial and error using plant materials, ethnopharmacology observing indigenous drug uses, and serendipitous discoveries like penicillin. Rational drug design is target-based, using the known structure and function of targets. Methods include ligand-based approaches like quantitative structure-activity relationships (QSAR) and pharmacophore modeling, and structure-based approaches like molecular docking and de novo design using a target's 3D structure. Both traditional and rational methods have contributed to modern drug discovery.